PharVision Advisers’s EnerSys ENS Stock Holding History

PharVision Advisers’s Portfolio ENS Stock Details ENS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,103	Closed	-$376K	–	315
2025 Q1	$376K	Buy	+4,103	New	+$400K	0.52%	52

Other funds holding ENS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

NSCM

New South Capital Management Memphis, Tennessee $2.28B AUM 47.19% 1-Year Est. Return

PharVision Advisers's ENS Position: Q2 2025 in Review

PharVision Advisers sold out of EnerSys (ENS) in Q2 2025, closing a stake of 4,103 shares — an estimated $376K sold.

PharVision Advisers first reported a position in ENS in Q1 2025 and held it in 1 quarter. The position peaked at $376K in Q1 2025. 369 funds tracked by Wall St. Rank hold ENS as of Q2 2025.

PharVision Advisers reported no remaining EnerSys position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 4,103 EnerSys shares in Q2 2025, an estimated $376K.
PharVision Advisers first reported a position in EnerSys in Q1 2025 and held it in 1 quarter.
PharVision Advisers's EnerSys position peaked at $376K in Q1 2025.
369 funds tracked by Wall St. Rank held EnerSys as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.